Carles Cantí (C Cantí)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 5

Top Topics

Circulating Tumor Cells

Endoplasmic Reticulum Stress

Top Venues

Cell death & disease

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Clara Bayona, Lía Alza, Teodora Randelovic, Marta C Sallán, Anna Visa, Carles Cantí, Ignacio Ochoa, Sara Oliván, Judit Herreros
Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach. Cell death & disease 15 (2) (2024)
Clara Bayona, Lía Alza, Teodora Randelovic, Marta C Sallán, Anna Visa, Carles Cantí, Ignacio Ochoa, Sara Oliván, Judit Herreros
Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach. Cell death & disease 15 (2) (2024)
Clara Bayona, Lía Alza, Teodora Randelovic, Marta C Sallán, Anna Visa, Carles Cantí, Ignacio Ochoa, Sara Oliván, Judit Herreros
Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach. Cell death & disease 15 (2) (2024)
Mireia Nàger, Marta C Sallán, Anna Visa, Charumathi Pushparaj, Maria Santacana, Anna Macià, Andrée Yeramian, Carles Cantí, Judit Herreros
Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers. Autophagy 14 (4) (2018)
A Macià, Judit Herreros, Rosa María Martí, Carles Cantí
Corrigendum to "Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma". BioMed research international 2016 (2016)